Merck Total Liabilities 2010-2024 | MKKGY
Merck total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Merck total liabilities for the quarter ending June 30, 2024 were $22.894B, a 4.61% decline year-over-year.
- Merck total liabilities for 2023 were $23.53B, a 0.83% decline from 2022.
- Merck total liabilities for 2022 were $23.728B, a 16.25% decline from 2021.
- Merck total liabilities for 2021 were $28.332B, a 0.09% increase from 2020.
Merck Annual Total Liabilities
(Millions of US $) |
| 2023 |
$23,530 |
| 2022 |
$23,728 |
| 2021 |
$28,332 |
| 2020 |
$28,305 |
| 2019 |
$29,006 |
| 2018 |
$23,213 |
| 2017 |
$24,362 |
| 2016 |
$26,781 |
| 2015 |
$27,911 |
| 2014 |
$18,888 |
| 2013 |
$12,950 |
| 2012 |
$14,441 |
| 2011 |
$16,196 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Total Liabilities
(Millions of US $) |
| 2024-06-30 |
$22,894 |
| 2024-03-31 |
$23,267 |
| 2023-12-31 |
$23,530 |
| 2023-09-30 |
$23,523 |
| 2023-06-30 |
$24,000 |
| 2023-03-31 |
$24,052 |
| 2022-12-31 |
$23,728 |
| 2022-09-30 |
$22,759 |
| 2022-06-30 |
$24,146 |
| 2022-03-31 |
$26,086 |
| 2021-12-31 |
$28,332 |
| 2021-09-30 |
$27,307 |
| 2021-06-30 |
$28,657 |
| 2021-03-31 |
$30,029 |
| 2020-12-31 |
$28,305 |
| 2020-09-30 |
$29,500 |
| 2020-06-30 |
$28,404 |
| 2020-03-31 |
$28,841 |
| 2019-12-31 |
$29,006 |
| 2019-09-30 |
$26,560 |
| 2019-06-30 |
$24,721 |
| 2019-03-31 |
$23,898 |
| 2018-12-31 |
$23,213 |
| 2018-09-30 |
$23,711 |
| 2018-06-30 |
$24,966 |
| 2018-03-31 |
$25,900 |
| 2017-12-31 |
$24,362 |
| 2017-09-30 |
$25,902 |
| 2017-06-30 |
$25,308 |
| 2017-03-31 |
$25,438 |
| 2016-12-31 |
$26,781 |
| 2016-09-30 |
$26,505 |
| 2016-06-30 |
$27,302 |
| 2016-03-31 |
$27,149 |
| 2015-12-31 |
$27,911 |
| 2015-09-30 |
$20,298 |
| 2015-06-30 |
$17,589 |
| 2015-03-31 |
$19,118 |
| 2014-12-31 |
$18,888 |
| 2014-09-30 |
$14,512 |
| 2014-06-30 |
$14,077 |
| 2014-03-31 |
$13,384 |
| 2013-12-31 |
$12,950 |
| 2013-09-30 |
$13,969 |
| 2013-06-30 |
$14,698 |
| 2013-03-31 |
$15,110 |
| 2012-12-31 |
$14,441 |
| 2012-09-30 |
$14,645 |
| 2012-06-30 |
$14,601 |
| 2012-03-31 |
|
| 2011-12-31 |
$16,196 |
| 2011-09-30 |
|
| 2011-06-30 |
$16,602 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$16,096 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
